Benjamin Z. Galper

发表

Cost-effectiveness analysis of short-duration dual antiplatelet therapy with newer drug-eluting stent platforms versus longer-duration dual antiplatelet therapy with a second-generation drug-eluting stent in elective percutaneous coronary intervention

R. Yeh, D. Cohen, E. Secemsky, 2019, Coronary artery disease.

Cost-Effectiveness of Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis Versus Surgical Aortic Valve Replacement.

D. Adams, C. Meduri, J. Popma, 2016, Journal of the American College of Cardiology.

Association of body mass index with mortality and cardiovascular events for patients with coronary artery disease: a systematic review and meta-analysis

F. Gao, L. Mauri, R. Yeh, 2015, Heart.

Late stent thrombosis: can it be prevented?

L. Mauri, Benjamin Z. Galper, 2014, JACC. Cardiovascular interventions.

The Role of New Antiplatelet Agents in Percutaneous Coronary Intervention

R. Mehran, Benjamin Z. Galper, 2009 .

Health Services and Outcomes Research Using Stress Testing to Guide Primary Prevention of Coronary Heart Disease Among Intermediate-Risk Patients A Cost-Effectiveness Analysis

L. Goldman, M. Pletcher, N. Rodondi, 2012 .

Cost‐Effectiveness of Supervised Exercise, Stenting, and Optimal Medical Care for Claudication: Results From the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) Trial

E. Mohler, J. Regensteiner, D. Cohen, 2014, Journal of the American Heart Association.

Antiplatelets and Antithrombotics The Role of New Antiplatelet Agents in Percutaneous Coronary Intervention

R. Mehran, Benjamin Z. Galper, 2009 .

Use of Cardiac Computerized Tomography to Predict Neo–Left Ventricular Outflow Tract Obstruction Before Transcatheter Mitral Valve Replacement

Deepak L. Bhatt, C. Don, R. Blankstein, 2017, Journal of the American Heart Association.

Updating the chest pain algorithm: incorporating new evidence on emerging antiplatelet agents.

G. Stone, J. Moses, J. Giglio, 2011, Critical pathways in cardiology.

Comparison of adverse event and device problem rates for transcatheter aortic valve replacement and Mitraclip procedures as reported by the Transcatheter Valve Therapy Registry and the Food and Drug Administration postmarket surveillance data

Benjamin Z. Galper, David E Beery, Gregory Leighton, 2018, American heart journal.

Calcific Aortic Stenosis: New Approaches to an Old Disease.

Benjamin Z. Galper, J. Kennett, 2016, Missouri medicine.

LTC4 production by eosinophils in asthmatic subjects with alternative forms of ALOX-5 core promoter.

E. Israel, J. Drazen, O. Kalayci, 2003, Advances in experimental medicine and biology.

Ontogeny of the eotaxins in human lung.

K. Haley, Benjamin Z. Galper, C. Lilly, 2008, American journal of physiology. Lung cellular and molecular physiology.

The American College of Cardiology Ventures Into Medical Research and Innovation Policy.

P. O'Gara, Benjamin Z. Galper, 2016, Journal of the American College of Cardiology.

Myocardial bridging in a man with non-ST-elevation myocardial infarction.

Deepak L. Bhatt, A. Shah, Benjamin Z. Galper, 2015, Circulation.

Necessity is the mother of invention: The unofficial pathway from off-label to approved.

A. Goldsweig, Benjamin Z. Galper, 2021, Cardiovascular revascularization medicine : including molecular interventions.

Strategies for Primary Prevention of Coronary Heart Disease Based on Risk Stratification by the ACC/AHA Lipid Guidelines, ATP III Guidelines, Coronary Calcium Scoring, and C-Reactive Protein, and a Global Treat-All Strategy: A Comparative--Effectiveness Modeling Study

A. Einstein, Benjamin Z. Galper, Y. C. Wang, 2015, PloS one.

Balancing the risks of bleeding and stent thrombosis: a decision analytic model to compare durations of dual antiplatelet therapy after drug-eluting stents.

L. Mauri, R. Yeh, D. Cohen, 2015, American heart journal.

Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysis

L. Mauri, R. Yeh, P. Steg, 2015, The Lancet.

Using Stress Testing to Guide Primary Prevention of Coronary Heart Disease Among Intermediate-Risk Patients: A Cost-Effectiveness Analysis

L. Goldman, M. Pletcher, N. Rodondi, 2012, Circulation.

Antiplatelet Therapy After Coronary Stenting

L. Mauri, Benjamin Z. Galper, 2013, Current Treatment Options in Cardiovascular Medicine.

Conflict in the care of patients with prolonged stay in the ICU: types, sources, and predictors

T. Brennan, A. Puopolo, D. Studdert, 2003, Intensive Care Medicine.

#SoMe for #IC: Optimal use of social media in interventional cardiology

Matthew J. Daniels, A. Goldsweig, S. Arnold, 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Economic Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Low Surgical Risk: Results from the PARTNER 3 Trial

M. Leon, S. Kapadia, Craig R. Smith, 2023, Circulation.

Can Transcatheter Aortic Valve Replacement Cure Cardiorenal Syndrome?

Benjamin Z. Galper, 2021, JAMA Network Open.

TCT-786 Cost Effectiveness of the MitraClip® Compared with Mitral Valve Surgery: 12-month Results from the EVEREST II Randomized Controlled Trial

L. Mauri, D. Glower, T. Feldman, 2012 .

TAVR and the Kidney: Is This the Beginning of a Beautiful Friendship?

Deepak L. Bhatt, A. Goldsweig, Benjamin Z. Galper, 2020, Journal of the American College of Cardiology.

TCT-451 Thirty-Day Outcomes After Next-Day Discharge in Transcatheter Aortic Valve Replacement: Analysis of the STS/ACC TVT Registry

A. Kini, Benjamin Z. Galper, P. Sorajja, 2021, Journal of the American College of Cardiology.